HAE लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 20:40):

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital...

Stats
आज की मात्रा	93 659.00
औसत मात्रा	480 881
बाजार मूल्य	4.90B
EPS	$0 ( 2024-02-08 )
अगली कमाई की तारीख	( $0.880 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.21
ATR14	$0.114 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-02	Darecca James	Sell	432	Common Stock
2024-04-15	Lingamneni Anila	Sell	184	Common Stock
2024-03-11	Simon, Christopher	Sell	38 900	Common Stock
2023-11-01	Galvin Roy	Sell	160	Common Stock
2023-10-20	Basil Michelle L	Sell	197	Common Stock

INSIDER POWER
-12.57
Last 95 transactions
Buy: 406 848 \| Sell: 507 219

मात्रा सहसंबंध

लंबा: -0.28 (neutral)

छोटा: 0.17 (neutral)

Signal:(60.068) Neutral

Haemonetics Corp सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Haemonetics Corp सहसंबंध - मुद्रा/वस्त्र

-0.57
( weak negative )

-0.44
( neutral )

0.00
( neutral )

-0.57
( weak negative )

-0.35
( neutral )

0.36
( neutral )

Haemonetics Corp वित्तीय

Annual	2023
राजस्व:	$1.17B
सकल लाभ:	$615.10M (52.63 %)
EPS:	$2.27

FY	2023
राजस्व:	$1.17B
सकल लाभ:	$615.10M (52.63 %)
EPS:	$2.27

FY	2023
राजस्व:	$1.17B
सकल लाभ:	$615.10M (52.63 %)
EPS:	$0

FY	2022
राजस्व:	$993.20M
सकल लाभ:	$505.50M (50.90 %)
EPS:	$0.850

Financial Reports:

No articles found.

Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

के लिए वास्तविक समय के अद्यतन Haemonetics Corp [HAE]

Upcoming Earnings Alert